Reseller Terms & Conditions

suPAR Biomarker LLC d/b/a suPAR Bio

MD Reseller Terms and Conditions

Effective Date: March 1st, 2026

By creating an account, placing an order, or accessing the Partner Portal, Physician agrees to these Terms.

Introduction

These MD Reseller Terms and Conditions (“Terms”) are issued by suPAR Biomarker LLC, a limited liability company doing business as “suPAR Bio” (“suPAR Bio,” “Company,” “we,” or “us”). These Terms govern the purchase, resale, and permitted use of the suPARbio™ Systemic Chronic Inflammation Test, including the associated specimen collection kit, instructions for use, and related materials (collectively, the “suPAR Bio Test”), by a licensed physician (“Physician” or “you”).

By purchasing, accessing, or offering the suPAR Bio Test, Physician acknowledges and agrees to be legally bound by these Terms. If Physician does not agree to these Terms, Physician may not purchase, access, or offer the suPAR Bio Test.

Definitions

For purposes of these Terms:

“suPAR Bio Test” means the suPARbio™ Systemic Chronic Inflammation Test, consisting of the specimen collection kit and related services for quantitative measurement of soluble urokinase plasminogen activator receptor (suPAR) in human plasma (EDTA) samples performed by a third-party CLIA-certified laboratory.

“suPAR Bio Kit” means the suPAR Bio–branded specimen collection kit provided by suPAR Bio, including its contents, packaging, instructions for use, and accompanying educational materials, intended for collection and submission of a patient specimen for suPAR testing performed by a third-party CLIA-certified laboratory.

“Result Report” means the branded interpretive report generated by suPAR Bio following receipt of the quantitative suPAR concentration (ng/mL) issued by the performing CLIA-certified laboratory. The Result Report incorporates the laboratory-reported suPAR value and presents it together with standardized, non-diagnostic interpretive categorizations (including low, moderate, or severe systemic chronic inflammation), applicable reference intervals, a suPAR Bio Age Index derived from population-level reference data, visual representations, explanatory content, and any applicable alert or Severe Result Protocol notification. The Result Report does not replace, modify, or supersede the official laboratory report and is based solely on the quantitative result provided by the performing laboratory.

“suPAR Bio Partner Portal” means the secure online ordering and account management platform operated by suPAR Bio through which authorized physicians create accounts, verify licensure, access pricing, place orders, and access related reporting materials.

“Blood Draw Quick Guide” means the written instructions included with the suPAR Bio Test kit providing guidance to licensed healthcare professionals regarding specimen collection, centrifugation, plasma preparation, labeling, packaging, and same-day shipment requirements for overnight delivery to the performing laboratory.

“Severe Result Protocol” means suPAR Bio’s internal administrative notification process triggered when a laboratory-reported suPAR concentration exceeds 6.0 ng/mL (or such threshold as may be updated by suPAR Bio based on scientific or operational considerations). The Severe Result Protocol may include flagging the result within the suPAR Bio Partner Portal and providing notification to the Physician that the result exceeds the designated threshold and that clinical follow-up may be warranted. The Severe Result Protocol is administrative in nature, does not constitute medical advice, diagnosis, or treatment recommendation, and does not transfer or create any clinical duty of care on the part of suPAR Bio.

Scope of Agreement

Subject to Physician’s acceptance of these Terms and verification of licensure and eligibility through the suPAR Bio Partner Portal, suPAR Bio authorizes Physician to purchase the suPAR Bio Test for resale directly to Physician’s own patients within the ordinary course of Physician’s licensed medical practice.

This authorization is limited to use within Physician’s practice and does not grant any right to distribute, sublicense, assign, or otherwise make the suPAR Bio Test available to other providers, medical practices, entities, third-party platforms, online marketplaces, or subscription models without the prior written consent of suPAR Bio.

All purchases of the suPAR Bio Test are subject to these Terms as in effect at the time of order placement. No broader distribution rights, commercial agency, or partnership relationship is created by this authorization.

Eligibility and Permitted Use

By purchasing, accessing, or offering the suPAR Bio Test, Physician represents and warrants that Physician is a duly licensed medical doctor in good standing in each jurisdiction in which Physician practices, and that Physician maintains all required professional licenses, registrations, and certifications necessary to order and provide diagnostic testing services.

Physician further represents that the suPAR Bio Test is being acquired solely for resale to Physician’s own patients within the ordinary course of Physician’s licensed medical practice and consistent with Physician’s independent medical judgment.

Acceptance of these Terms constitutes a binding agreement governing Physician’s purchase, resale, and permitted use of the suPAR Bio Test.

License Grant and Distribution Restrictions

Subject to Physician’s compliance with these Terms, suPAR Bio grants Physician a limited, non-exclusive, non-transferable, non-sublicensable, and revocable license to purchase and resell the suPAR Bio Test solely to Physician’s own patients within Physician’s licensed medical practice.

No distribution, agency, reseller-to-reseller, sublicensing, or appointment rights are granted under these Terms. Physician shall not resell, transfer, assign, delegate, distribute, or otherwise make the suPAR Bio Test available to:

• other healthcare providers
• medical practices or entities
• management services organizations (MSOs)
• third-party administrators
• group purchasing organizations
• online marketplaces
• subscription models
• wellness organizations
• digital health platforms
• or any intermediary distribution channel

without the prior written consent of suPAR Bio.

Physician may not engage in wholesale redistribution, bulk resale to third parties, indirect distribution arrangements, or pooled purchasing structures.

Any attempted assignment or transfer of rights under these Terms without prior written consent shall be void. All rights not expressly granted are reserved by suPAR Bio. suPAR Bio reserves the right to suspend or terminate purchasing privileges and access to the suPAR Bio Partner Portal upon breach of this Section.

Bulk Purchase, Ordering Authority, and Result Access

Physician acknowledges and agrees that purchase of the suPAR Bio Test in bulk through the suPAR Bio Partner Portal will result in Physician having access to laboratory reports and associated Result Reports for any suPAR Bio Test ordered under Physician’s account.

Physician represents and warrants that each suPAR Bio Test purchased under Physician’s account shall be offered only to Physician’s own patients with whom Physician has established a bona fide physician–patient relationship consistent with applicable law. Accordingly, bulk purchases do not create any right to redistribute tests to third parties for independent ordering, interpretation, or patient management. 

Physician is solely responsible for ensuring that patients are informed that test results will be reported to Physician as the purchasing provider and that such reporting is consistent with Physician’s privacy practices and applicable law.

Physician shall not purchase suPAR Bio Tests for the purpose of redistribution to other providers, intermediaries, corporate entities, wellness platforms, screening programs, or third-party sellers where Physician does not maintain clinical responsibility for the patient whose specimen is tested.

Any use of the suPAR Bio Test inconsistent with this Section constitutes a material breach of these Terms.

Independent Contractor Status and No Shared Clinical Duty

Physician acknowledges that Physician operates as an independent healthcare provider and that no joint venture, shared clinical program, co-management arrangement, or enterprise liability relationship is created by these Terms.

suPAR Bio does not supervise, direct, or control Physician’s clinical practice, patient selection criteria, follow-up protocols, or care pathways.

No shared duty of care, co-treatment relationship, or collaborative medical management obligation is created between suPAR Bio and Physician.

Physician remains solely responsible for establishing clinical protocols, documenting medical necessity, maintaining patient records, and complying with professional standards of care.

Clinical Responsibility and Independent Medical Judgment

Physician acknowledges and agrees that all clinical interpretation, patient counseling, diagnostic assessment, treatment decisions, and medical judgment related to the suPAR Bio Test, the official laboratory report, and the Result Report are solely the responsibility of Physician. The Result Report applies standardized, non-diagnostic interpretive criteria to the laboratory-reported quantitative suPAR value and is provided for informational purposes only; it does not constitute a medical diagnosis, treatment recommendation, or standard of care.

Physician further acknowledges that the decision to order, offer, recommend, or utilize the suPAR Bio Test for any patient is based exclusively on Physician’s independent professional judgment and clinical discretion. suPAR Bio may facilitate administrative aspects of test ordering and reporting, including coordination with a performing CLIA-certified laboratory and generation of the Result Report incorporating quantitative values, reference ranges, interpretive inflammation categories, a suPAR Bio Age Index, and applicable notifications. Such activities are administrative and informational in nature.

suPAR Bio does not practice medicine, does not provide medical advice, and does not establish any physician–patient relationship. suPAR Bio does not control or supervise Physician’s clinical decision-making, patient communications, billing practices, treatment recommendations, or follow-up care.

Physician remains solely responsible for patient evaluation, informed consent, counseling, and follow-up, including in circumstances where a Result Report categorizes a result as elevated or severe or triggers a Severe Result Protocol notification. To the fullest extent permitted by law, suPAR Bio shall not be liable for any claims, damages, regulatory actions, or liabilities arising from Physician’s reliance upon or interpretation of the laboratory report or Result Report, or from any action or inaction taken in connection therewith.

The suPAR Bio Test does not constitute a standard-of-care screening requirement for any patient population and is not intended to replace clinical guidelines or professional society recommendations.

Operational Support and Reporting Process

Physician acknowledges that, in connection with the suPAR Bio Test, suPAR Bio will facilitate submission of the test order to the performing CLIA-certified laboratory in the state where services are rendered, including coordinating the ordering process through an appropriately licensed ordering physician where required by applicable law, even in instances where a separate physician initiates the physical kit purchase. Such facilitation is administrative in nature and does not constitute the practice of medicine.

Following laboratory analysis, the performing CLIA-certified laboratory will issue an official laboratory report reflecting the quantitative suPAR concentration (ng/mL). Upon receipt of the laboratory-reported value, suPAR Bio generates a branded Result Report that incorporates the laboratory result and applies standardized interpretive criteria derived from population-level reference data to categorize systemic chronic inflammation status and calculate the suPAR Bio Age Index. The Result Report is informational in nature and is intended to assist the ordering physician in contextualizing the laboratory value; it does not alter, supersede, or replace the official laboratory report.

In the event a suPAR result exceeds 6.0 ng/mL, suPAR Bio will implement its internal “Severe Result Protocol,” which includes flagging the result and providing notification to the ordering physician that follow-up evaluation is recommended. Physician acknowledges and agrees that responsibility for contacting the patient, conducting further evaluation, and determining appropriate clinical management remains solely with Physician. suPAR Bio’s notification procedures are administrative safeguards and do not transfer or assume any clinical duty of care.

Moderate and Elevated Result Clinical Follow-Up

Physician acknowledges that suPAR levels categorized as Moderate Systemic Chronic Inflammation (3.0–6.0 ng/mL) or Elevated Systemic Chronic Inflammation (>6.0 ng/mL) reflect biomarker values associated in published literature with increased inflammatory burden and potential underlying health risk.

Physician further acknowledges that such categorizations are not diagnostic but may warrant further clinical consideration, evaluation, or monitoring based on Physician’s independent medical judgment and the patient’s clinical presentation.

In the event a suPAR result exceeds 6.0 ng/mL, suPAR Bio will implement its internal “Severe Result Protocol,” which includes flagging the result and providing administrative notification to the ordering physician that follow-up evaluation is recommended.Physician acknowledges an obligation to timely review the Result Report of all patients for which they were a reseller including laboratory reports and any flagged results generated through the Severe Result Protocol and to exercise independent clinical judgment in determining appropriate patient communication and management.

For results categorized as Moderate Systemic Chronic Inflammation (3.0–6.0 ng/mL), Physician acknowledges that clinical discretion should be exercised in determining whether lifestyle counseling, risk factor assessment, repeat testing, or further evaluation is appropriate.

suPAR Bio does not monitor patient outcomes, enforce follow-up, or assume any duty to ensure that Physician conducts further evaluation or management. All medical decision-making and patient follow-up obligations remain exclusively with Physician.

FDA & Regulatory Status Disclosure

The following statements describe the intended use, validation status, and regulatory positioning of the suPARbio™ Systemic Chronic Inflammation Test (the “suPAR Bio Test”). Physician acknowledges that the suPAR Bio Test is offered subject to the disclosures set forth below and agrees to present the suPAR Bio Test to patients in a manner consistent with these statements:

The suPARbioTM Systemic Chronic Inflammation Test is a quantitative in vitro diagnostic test for the measurement of soluble urokinase plasminogen activator receptor (suPAR) in human plasma (EDTA) samples.

The test is intended for use in conjunction with other clinical and laboratory findings as an aid in the assessment of systemic chronic inflammation status in adults. Elevated suPAR levels may indicate the presence of chronic low-grade inflammation.

Serial measurements of suPAR may be used to monitor changes in chronic inflammation status over time, including in response to lifestyle interventions such as dietary changes, exercise programs, weight management, and smoking cessation.

Results are reported as suPAR concentration (ng/mL) with age- and sex-adjusted reference ranges derived from a healthy adult population ages 18-65. A Biological Age Index, representing the chronological age at which the measured suPAR level is typical for healthy individuals, may also be reported.

This test is intended for use by trained clinical laboratory personnel in clinical laboratories or point-of-care settings. This test is not intended to diagnose any specific disease or condition.

This test has been validated by [insert Laboratory Name sample was processed at] under CLIA regulations for Laboratory Developed Tests (LDTs). It has not been cleared or approved by the U.S. Food and Drug Administration.

This test is not intended to diagnose, treat, cure, or prevent any specific disease or condition.

suPAR is a non-specific marker of inflammation and may be elevated in various conditions including serious acute infections, chronic diseases, and other inflammatory states.

Results should be interpreted by a qualified healthcare provider in conjunction with clinical history, symptoms, and other laboratory findings.

The Biological Age Index is a statistical estimate based on population-level data and should not be considered a definitive measure of physiological age.

Reference ranges are derived from Northern European populations and may not be directly applicable to all ethnic groups.

Physician acknowledges and agrees that suPAR Bio does not represent the suPAR Bio Test as diagnostic, predictive, or intended to treat, cure, or prevent any disease, and that the suPAR Bio Test has not been cleared or approved by the U.S. Food and Drug Administration. Physician further agrees not to represent or market the suPAR Bio Test as FDA-approved and to present the suPAR Bio Test to patients in a manner consistent with the disclosures set forth above.

No Guarantees of Clinical Outcomes

The suPAR Bio Test and Result Report are provided as informational laboratory-based tools. suPAR Bio makes no representations or warranties regarding clinical outcomes, patient improvement, disease prevention, risk reduction, longevity, therapeutic response, or the effectiveness of any lifestyle or medical intervention. suPAR Bio does not guarantee that any patient’s suPAR level will change, improve, or correlate with any specific clinical outcome. Physician acknowledges that clinical utility depends on Physician’s independent medical judgment and individual patient circumstances.

Demographic Applicability; Adult Use Limitation

Physician acknowledges that the suPAR Bio Test reference ranges, interpretive categories, and suPAR Bio Age Index calculations are derived from population-level data based on healthy Danish blood donors aged 18 to 65 years and reflect sex-adjusted reference intervals established from Northern European populations.

Physician acknowledges that such reference data may not be directly applicable to all ethnic groups, geographic populations, or individuals outside the validated age range. Physician further acknowledges that extrapolation of interpretive thresholds or Biological Age Index calculations beyond the validated population requires independent clinical judgment.

The suPAR Bio Test is intended for use in adults. The suPAR Bio Test is not intended for use in minors under eighteen (18) years of age. Physician shall not order, offer, or utilize the suPAR Bio Test for pediatric patients.

Physician assumes sole responsibility for evaluating the appropriateness of the suPAR Bio Test in patients outside the validated demographic reference population and for interpreting results in such patients using independent medical judgment.

suPAR Bio shall not be liable for any claims arising from use of the suPAR Bio Test in populations outside the validated age or reference demographic parameters.

Intended Use Limitation and Prohibition on Modification

Physician shall not alter, modify, expand, reinterpret, or combine the suPAR Bio Test, the Result Report, interpretive categorizations, reference ranges, or suPAR Bio Age Index with other biomarkers, algorithms, risk scoring systems, or proprietary frameworks in a manner that creates a new diagnostic claim, screening tool, predictive model, or composite health product.

Physician shall not market or position the suPAR Bio Test for any use beyond the intended use disclosures expressly set forth in these Terms and approved materials.

Any modification, reinterpretation, or expanded promotional claim may constitute unauthorized labeling and is strictly prohibited.

No Referral, Kickback, or Reimbursement-Based Compensation

The parties acknowledge that these Terms govern solely the purchase by Physician of the suPAR Bio Test as a product for resale within Physician’s own licensed medical practice. The suPAR Bio Test is offered on a private-pay basis, and suPAR Bio does not bill, submit claims to, or seek reimbursement from Medicare, Medicaid, TRICARE, or any other federal or state healthcare program in connection with the suPAR Bio Test.

No payments, discounts, credits, rebates, or other remuneration are offered, paid, solicited, or received to induce or reward referrals, ordering, recommending, arranging for, or generating business reimbursable under any federal or state healthcare program.

Physician represents and warrants that Physician’s purchase and resale of the suPAR Bio Test, and any clinical services independently provided by Physician in connection therewith, shall be conducted in full compliance with all applicable federal, state, and local healthcare fraud and abuse laws, including, without limitation:

(i) the federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b);
(ii) the Eliminating Kickbacks in Recovery Act of 2018 (“EKRA”), 18 U.S.C. § 220;
(iii) the federal physician self-referral law (Stark Law), 42 U.S.C. § 1395nn, to the extent applicable;
(iv) any applicable state anti-kickback, fee-splitting, patient brokering, self-referral, or similar statutes; and
(v) any successor statutes, implementing regulations, or enforcement guidance related thereto.

Physician further represents and warrants that no arrangement contemplated by these Terms is intended to, nor shall it, constitute unlawful remuneration or an improper inducement under such laws.

If Physician elects to submit claims to any commercial or governmental payor in connection with services incorporating the suPAR Bio Test, Physician shall do so solely at Physician’s discretion and responsibility and shall ensure full compliance with applicable billing, reimbursement, and disclosure requirements. suPAR Bio makes no representations regarding reimbursement, coverage, or coding and assumes no responsibility for any billing submitted by Physician.

No Volume Conditioning or Incentive Programs

Physician acknowledges and agrees that pricing, access, support services, educational materials, or portal functionality are not conditioned upon referral volume, order frequency, patient volume, or any expectation of future business.

suPAR Bio does not offer, and Physician shall not request or expect, any rebate, incentive, tiered pricing adjustment, marketing benefit, or other remuneration based upon the number of tests ordered, frequency of use, or revenue generated.

Physician further acknowledges that no aspect of the relationship between Physician and suPAR Bio is intended to induce referrals or generate business reimbursable by any federal or state healthcare program.

Direct Billing States 

Physician acknowledges that certain states impose specific restrictions relating to direct billing, fee-splitting, diagnostic testing, and related healthcare remuneration arrangements. In order to ensure regulatory compliance and uniform administration of its program, suPAR Bio does not currently authorize the resale,  offering, or facilitation of the suPAR Bio Test within the State of New York. Accordingly, Physician agrees that Physician shall not resell, distribute, or otherwise facilitate use of the suPAR Bio Test in the State of New York unless and until expressly authorized in writing by suPAR Bio.

With respect to the States of New Jersey, Rhode Island and any additional States with additional direct billing requirements, Physician acknowledges that suPAR Bio remits laboratory service fees directly to the performing CLIA-certified laboratory in connection with the suPAR Bio Test, and that such payment structure is implemented for the purpose of complying with applicable state direct billing and diagnostic testing laws. Physician further acknowledges that Physician does not receive, and shall not solicit, accept, or retain, any portion of laboratory service fees in such jurisdictions. Physician represents and warrants that Physician has independently determined that Physician’s purchase and resale of the suPAR Bio Test is permitted under the laws of the state(s) in which Physician practices and assumes full responsibility for compliance with all applicable state-specific direct billing, fee-splitting, and professional practice requirements.

Regulatory Changes and Compliance Adjustments

Physician acknowledges that the suPAR Bio Test is offered pursuant to a Laboratory Developed Test (“LDT”) framework and that applicable federal, state, and regulatory requirements governing laboratory testing, diagnostic distribution, reporting, marketing, or oversight may change.

In the event of any change in law, regulation, agency guidance, enforcement policy, licensure requirement, laboratory certification requirement, or governmental directive that, in suPAR Bio’s reasonable judgment, materially impacts the legal permissibility of offering the suPAR Bio Test, suPAR Bio reserves the right to modify, suspend, restrict, or discontinue distribution pending compliance review.

suPAR Bio shall not be liable for any interruption or suspension arising from compliance with governmental requirements or enforcement actions.

Product Evolution and Platform Updates

Physician acknowledges that the suPAR Bio Test, including laboratory partnerships, reporting formats, interpretive methodologies, reference intervals, and commercialization structure, may evolve over time to reflect scientific advancements, validation updates, operational improvements, or business considerations.

suPAR Bio reserves the right to update, enhance, modify, or transition the suPAR Bio Test, including movement between LDT status and other lawful regulatory pathways, in its sole discretion.

Such updates shall not constitute a breach of these Terms.

Adverse Event, Complaint, and Regulatory Reporting

Physician agrees to promptly notify suPAR Bio of any known or suspected adverse events, patient complaints, unexpected clinical outcomes, specimen integrity issues, quality concerns, or regulatory inquiries relating to the suPAR Bio Test, the Result Report, specimen collection, laboratory processing, or related services.

For purposes of this Section, an “adverse event” includes any unintended or undesirable experience, injury, clinical complication, or significant negative outcome that may reasonably be associated with use of the suPAR Bio Test, specimen collection, result interpretation, or follow-up actions taken in response to a Result Report.

Physician shall provide such notification via electronic mail to compliance@suparbio.com within a commercially reasonable timeframe after becoming aware of the matter and shall cooperate with suPAR Bio in any investigation, documentation, corrective action, or regulatory response deemed necessary by suPAR Bio.

Physician acknowledges that suPAR Bio may be required to assess and document complaints, quality concerns, or safety-related issues in accordance with applicable laws, regulatory guidance, or laboratory standards. Nothing in this Section transfers clinical responsibility to suPAR Bio or creates a physician–patient relationship between suPAR Bio and any patient.

Failure to report known adverse events or material complaints in accordance with this Section may constitute a material breach of these Terms.

Recordkeeping and Compliance Verification

Physician shall maintain accurate records sufficient to demonstrate compliance with these Terms, including records relating to use of approved marketing materials, branding, and representations concerning the suPAR Bio Test.

Upon reasonable written request, suPAR Bio may request copies of marketing materials, promotional communications, website content, or other public-facing materials referencing the suPAR Bio Test for the limited purpose of verifying compliance with approved claims, trademark usage, and regulatory representations under these Terms.

suPAR Bio’s review rights under this Section shall be limited to materials and information reasonably necessary to confirm compliance with marketing, branding, and representation requirements and shall not extend to access to patient medical records, protected health information, or confidential clinical documentation.

If suPAR Bio determines that any materials or representations are inconsistent with approved claims or these Terms, Physician shall promptly cease use and correct such materials. Failure to comply following notice may constitute a material breach of these Terms.

Nothing in this Section creates a duty for suPAR Bio to monitor or supervise Physician’s practice or marketing activities.

Pricing and Payment Terms

Access to pricing and purchasing privileges requires creation and approval of a Physician account through the suPAR Bio Partner Portal. Pricing for the suPAR Bio Test shall be displayed within the suPAR Bio Partner Portal and may be contingent upon verification of Physician’s NPI, licensure status, and any applicable authorization codes entered at the time of account setup.

suPAR Bio reserves the right to modify pricing at any time in its sole discretion. Any pricing changes shall apply only to orders placed after the effective date of such change. Orders that have been submitted and processed prior to a pricing modification shall not be retroactively adjusted.

Payment for all orders is due at the time of purchase unless otherwise agreed in writing. Physician agrees not to initiate chargebacks or payment reversals except in the case of demonstrable billing error. suPAR Bio reserves the right to suspend account access for failed payments, disputed charges, or unpaid balances. Excessive chargebacks or dispute activity may result in suspension.

Once an order has shipped, all sales are final and non-refundable, except as expressly provided in “Cancellations, Returns, and Damaged Kits” below.

Storage, Inspection, and Expiration

Upon receipt of each suPAR Bio Test kit, Physician shall promptly inspect the shipment and verify that all kit components listed in the kit insert are present and intact. If any required component is missing upon delivery, Physician shall notify suPAR Bio within a reasonable period, and such kit shall qualify for replacement in accordance with Section 14 (Cancellations, Returns, and Damaged Kits).

Physician acknowledges that expiration of the suPAR Bio Test is determined by the earliest expiration date of any individual component contained within the kit. suPAR Bio shall ship kits with a minimum of six (6) months remaining prior to expiration at the time of shipment.

Physician shall store all kits in accordance with the storage instructions provided in the kit insert. Unless otherwise specified in the insert, kits should be maintained at recommended room temperature in a protected, non-compressed environment to prevent breakage, degradation, or compromise of components. Physician shall not store kits in a manner that subjects them to excessive heat, cold, moisture, compression, or other environmental conditions inconsistent with provided instructions.

Expired kits shall not be used, resold, redistributed, or submitted for laboratory testing. Physician is solely responsible for monitoring inventory expiration dates and ensuring that expired kits are removed from use.

suPAR Bio shall not be liable for compromised results, rejected specimens, or damages arising from improper storage, failure to inspect upon receipt, environmental exposure, or use of expired kits.

Specimen Collection, Processing, Shipment, and Mobile Phlebotomy

Physician acknowledges that the suPAR Bio Test kit includes a Blood Draw Quick Guide containing required procedures for specimen collection, centrifugation, plasma preparation, labeling, packaging, and shipment. Physician shall ensure that all specimens are collected, processed, labeled, and shipped strictly in accordance with the Blood Draw Quick Guide and all instructions included in the kit insert.

Specimens must be centrifuged and prepared as instructed and shipped on the same calendar day as collection using the overnight shipping label provided with the kit, unless otherwise expressly authorized in writing by suPAR Bio. Physician acknowledges that timely shipment and proper processing are necessary to preserve specimen integrity and ensure laboratory acceptance.

All specimen collection, whether performed within Physician’s practice or through a third-party mobile phlebotomy service, is conducted under Physician’s independent clinical authority and responsibility. Physician may utilize in-office personnel, independently retained mobile phlebotomy providers, or mobile collection services made available through the suPAR Bio platform; provided, however, that all such providers are independent third parties and not employees, agents, or representatives of suPAR Bio.

suPAR Bio may facilitate scheduling or coordination of third-party mobile phlebotomy services solely as an administrative convenience. suPAR Bio does not supervise, direct, or control specimen collection activities and does not provide clinical oversight of such services.

Physician remains solely responsible for ensuring proper patient identification, informed consent, clinical appropriateness of testing, and compliance with all applicable laws governing specimen collection. Physician further assumes responsibility for ensuring that all collection personnel are appropriately trained, qualified, and compliant with applicable professional standards.

suPAR Bio shall not be liable for rejected specimens, invalid or compromised samples, delayed reporting, shipping failures, laboratory refusal, consent deficiencies, labeling inaccuracies, improper centrifugation, failure to ship on the same day as collection, delays caused by late courier drop-off, failure of a specimen to arrive within required timeframes, or any claims, damages, or regulatory actions arising from specimen collection or shipment activities or any related damages from failure to comply with the Blood Draw Quick Guide.

This limitation applies to specimens collected within Physician’s office and to specimens collected by independently retained mobile phlebotomy providers, including providers not operating under suPAR Bio’s designated mobile phlebotomy network.

Failure to comply with the Blood Draw Quick Guide or shipment requirements constitutes a material deviation from required procedures and may result in specimen rejection without refund.

Licensure, Authority, and Insurance

Physician represents and warrants that Physician is duly licensed to practice medicine in each jurisdiction in which Physician offers or utilizes the suPAR Bio Test, and that such license is active, unrestricted, and in good standing. Physician further represents that Physician is not excluded, debarred, suspended, or otherwise ineligible to participate in any federal or state healthcare program.

Physician represents and warrants that Physician maintains professional liability (malpractice) insurance coverage in commercially reasonable amounts consistent with industry standards for Physician’s specialty and jurisdiction, and that such coverage shall remain in effect throughout the term of Physician’s participation under these Terms.

Physician shall promptly notify suPAR Bio of any suspension, restriction, investigation, exclusion, loss of licensure, lapse of insurance coverage, or other event that could materially affect Physician’s authority to order, offer, or resell the suPAR Bio Test.

Marketing, Communications, and Claims Control

Physician agrees that all marketing, promotional, educational, advertising, and patient-facing communications relating to the suPAR Bio Test (including the Result Report, interpretive categorizations, suPAR Bio Age Index, Severe Result Protocol, or any related services) shall strictly conform to materials expressly provided or approved in writing by suPAR Bio. Physician shall use only current versions of such approved materials and shall not distribute outdated, modified, excerpted, translated, or unapproved content.

Physician shall not alter, supplement, reinterpret, or create derivative marketing language or materials relating to the suPAR Bio Test without prior written authorization from suPAR Bio. Physician shall not make, publish, or communicate any claims, representations, or implications that are inconsistent with, exceed, expand upon, or differ from the statements contained in suPAR Bio’s approved materials, including but not limited to representations regarding diagnostic capability, predictive value, disease risk, longevity outcomes, therapeutic benefit, regulatory status, or clinical efficacy.

Without limitation, Physician shall not represent or imply that the suPAR Bio Test:
(i) diagnoses any specific disease or medical condition;
(ii) predicts specific clinical outcomes or mortality risk;
(iii) replaces comprehensive medical evaluation;
(iv) is cleared or approved by the U.S. Food and Drug Administration; or
(v) constitutes a definitive or validated measure of biological age or physiological health.

All public-facing communications, including website content, social media posts, press releases, interviews, podcasts, presentations, and patient handouts referencing the suPAR Bio Test, must remain consistent with suPAR Bio’s approved language. Physician acknowledges that unauthorized or misleading claims may expose suPAR Bio to regulatory enforcement, civil liability, or reputational harm.

Nothing in this Section prohibits Physician from independently reviewing peer-reviewed scientific literature, conducting independent clinical research, or forming professional opinions regarding suPAR or systemic inflammation within the scope of Physician’s professional practice. Physician may communicate independent scientific or clinical observations; provided, however, that Physician shall not attribute such statements to suPAR Bio, represent them as endorsed, validated, or approved by suPAR Bio, or use suPAR Bio’s name, trademarks, branding, or materials in connection with claims or interpretations that exceed or differ from suPAR Bio’s approved materials. Any such independent statements are made solely in Physician’s individual capacity and not on behalf of suPAR Bio.

Physician shall not state or imply that suPAR Bio has reviewed, endorsed, or adopted any independent research, analysis, or clinical conclusions unless expressly confirmed in writing by suPAR Bio. Physician shall not conduct or represent any formal clinical study, research trial, or publication involving the suPAR Bio Test using suPAR Bio trademarks or proprietary materials without prior written authorization.

Any violation of this Section constitutes a material breach of these Terms and may result in immediate suspension or termination of Physician’s authorization to purchase or resell the suPAR Bio Test, in addition to any other remedies available at law or in equity.

Trademarks and Brand Usage

All trademarks, service marks, trade names, logos, branding elements, product names (including suPARbio™ Systemic Chronic Inflammation Test and “suPAR Bio Test”), designs, graphics, and related intellectual property (collectively, the “Marks”) are and shall remain the exclusive property of suPAR Biomarker LLC d/b/a suPAR Bio. Nothing in these Terms grants Physician any ownership interest in the Marks.

Subject to compliance with these Terms, suPAR Bio grants Physician a limited, non-exclusive, non-transferable, revocable license to use the Marks solely in connection with the authorized resale and presentation of the suPAR Bio Test within Physician’s own medical practice and strictly in accordance with suPAR Bio’s approved marketing materials and brand guidelines.

Physician shall not modify, alter, distort, abbreviate, translate, combine with other marks, or create derivative works of the Marks without prior written authorization. Physician shall not register or attempt to register any trademark, trade name, domain name, social media handle, or other identifier that incorporates or is confusingly similar to the Marks.

Physician shall not use the Marks in any manner that suggests partnership, joint venture, endorsement beyond the scope of these Terms, or agency relationship between Physician and suPAR Bio. Physician shall not use the Marks in connection with unapproved claims, independent research publications, or marketing statements that exceed suPAR Bio’s approved materials.

All goodwill arising from use of the Marks shall inure solely to the benefit of suPAR Bio. suPAR Bio reserves the right to revoke the license granted under this Section at any time upon breach of these Terms.

Public Statements and Good-Faith Communications

Physician agrees not to make knowingly false, misleading, or bad-faith public statements about the suPAR Bio Test, suPAR Bio, or its services that are inconsistent with approved materials or that materially misrepresent the product’s intended use, regulatory status, or scientific basis.

Nothing in this Section shall restrict Physician from:
(i) engaging in good-faith scientific or clinical discussion;
(ii) reporting adverse events, quality concerns, or regulatory matters to appropriate authorities;
(iii) providing truthful testimony or responding to lawful subpoenas; or
(iv) communicating legitimate clinical observations to patients in the exercise of independent medical judgment.

This Section is intended solely to prevent bad-faith or knowingly false public representations and shall not be construed to restrict lawful, good-faith professional discourse.

Indemnification and Limitation of Liability

Physician Indemnification

Physician shall indemnify, defend, and hold harmless suPAR Biomarker LLC d/b/a suPAR Bio, and its affiliates, officers, directors, managers, employees, independent contractors, agents, and representatives, from and against any and all claims, demands, actions, investigations, proceedings, liabilities, damages, fines, penalties, losses, costs, and expenses (including reasonable attorneys’ fees) arising out of or relating to:

1. Physician’s clinical use of the suPAR Bio Test, or reliance upon or interpretation of the official laboratory report or Result Report;

2. any representations, statements, marketing communications, patient-facing materials, or public claims made by Physician that exceed, modify, or are inconsistent with suPAR Bio’s approved materials or intended use disclosures;

3. Physician’s failure to comply with applicable federal, state, or local healthcare laws or regulations, including but not limited to anti-kickback, fee-splitting, direct billing, professional licensure, or privacy requirements;

4. Physician’s provision of medical services, patient counseling, follow-up care, specimen collection activities, or clinical decision-making; or

5. any breach of these Terms.

Limitation of Liability

To the fullest extent permitted by law, suPAR Bio shall not be liable for any indirect, incidental, consequential, special, exemplary, or punitive damages, including but not limited to lost profits, loss of business opportunity, reputational harm, regulatory penalties, or costs of substitute services, arising out of or relating to the suPAR Bio Test, the official laboratory report, the Result Report, the suPAR Bio Partner Portal, or any related services, whether in contract, tort (including negligence), strict liability, or otherwise.

suPAR Bio’s total cumulative liability arising out of or relating to these Terms shall not exceed the total amount paid by Physician to suPAR Bio for the suPAR Bio Test during the twelve (12) months preceding the event giving rise to the claim.

The foregoing limitations shall not apply to:

1. suPAR Bio’s express indemnification obligations, if any, stated in these Terms;

2. liability arising from suPAR Bio’s fraud or willful misconduct; or

3. any liability that cannot be limited or excluded under applicable law.

Physician acknowledges that the pricing of the suPAR Bio Test reflects this allocation of risk between the parties.

HIPAA Compliance and Portal Access Responsibility

Physician represents and warrants that Physician is a licensed healthcare provider authorized to access protected health information (“PHI”) and to order diagnostic testing for patients within Physician’s practice.

Physician acknowledges that access to the suPAR Bio Partner Portal and associated patient result information is restricted to the authorized account holder tied to Physician’s NPI. Physician is solely responsible for maintaining the confidentiality and security of login credentials and for restricting portal access to authorized users within Physician’s practice.

If Physician designates additional personnel to access the suPAR Bio Partner Portal or patient result information, Physician represents and warrants that such individuals are appropriately authorized under applicable HIPAA and state privacy laws and are subject to appropriate confidentiality and data protection obligations. Physician assumes full responsibility for all access, use, or disclosure of patient information occurring through Physician’s account credentials.

suPAR Bio shall not be liable for any unauthorized access, misuse, disclosure, or HIPAA violation arising from credential sharing, internal practice access controls, or designation of users by Physician. Physician acknowledges that suPAR Bio does not supervise or control Physician’s internal privacy compliance practices.

Nothing in these Terms transfers HIPAA compliance responsibility from Physician to suPAR Bio with respect to Physician’s internal workforce or designated users.

Cancellations, Returns, and Damaged Kits

Physician may request cancellation of an order within a limited window between order submission and shipment confirmation. Once an order has shipped, it may not be canceled or returned except as expressly provided herein.

If a suPAR Bio Test kit is received in a damaged condition, Physician must notify suPAR Bio within a reasonable period after receipt and provide photographic or other reasonable documentation of the damage. Upon verification, suPAR Bio will replace the damaged kit at no additional cost. Any kit reported as damaged and approved for replacement shall have its corresponding kit identifier invalidated in suPAR Bio’s system and may not be used for specimen collection.

Physician shall not use, repurpose, disassemble, or salvage individual components of any kit reported as damaged for any collection services or other purposes. Unauthorized use of invalidated or damaged kit components constitutes a material breach of these Terms.

suPAR Bio reserves the right to deny replacement in cases of suspected misuse, improper storage, or abuse of the damaged kit policy.

Inventory Availability; No Guaranteed Supply

Physician acknowledges that availability of the suPAR Bio Test is subject to manufacturing capacity, component availability, laboratory capacity, regulatory requirements, shipping conditions, and other operational factors. suPAR Bio does not guarantee continuous, uninterrupted, or unlimited supply of kits.

All orders are subject to acceptance and fulfillment by suPAR Bio. suPAR Bio reserves the right, in its sole discretion, to limit quantities, delay shipment, allocate inventory, place products on backorder, suspend fulfillment, or discontinue the suPAR Bio Test at any time without liability.

Physician acknowledges that suPAR Bio shall not be liable for delays in shipment, temporary unavailability, inventory shortages, backorders, regulatory suspensions, laboratory capacity limitations, carrier delays, force majeure events, or other supply interruptions beyond suPAR Bio’s reasonable control.

Nothing in these Terms shall be construed as a guarantee of product availability, minimum supply, production continuity, or future product offerings.

Intellectual Property Ownership

All right, title, and interest in and to the suPAR Bio Test, the suPARbio™ Systemic Chronic Inflammation Test, the suPAR Bio Test name, logos, branding, trade dress, trademarks, service marks, proprietary methodologies, interpretive frameworks, result report formats, scoring systems (including any suPAR Bio Age Index), educational materials, scientific compilations, software, platform features, and all related intellectual property (collectively, “suPAR Bio Intellectual Property”) are and shall remain the exclusive property of suPAR Biomarker LLC d/b/a suPAR Bio.

Nothing in these Terms grants Physician any ownership interest in suPAR Bio Intellectual Property. Physician is granted only a limited, revocable, non-exclusive right to use approved trademarks and materials solely in accordance with these Terms.

Physician shall not register, attempt to register, claim ownership of, or assist any third party in registering any trademark, trade name, domain name, social media handle, or other designation that is identical to or confusingly similar to suPAR Bio Intellectual Property.

Physician shall not reverse engineer, modify, create derivative works from, or replicate the proprietary interpretive methodologies, scoring systems, or result reporting formats used by suPAR Bio.

Physician shall not attempt to replicate, extract, reverse engineer, or independently calculate the suPAR Bio Age Index or interpretive scoring methodology using laboratory values outside of the authorized Result Report format.

Any goodwill arising from use of suPAR Bio trademarks shall inure exclusively to the benefit of suPAR Bio.

Unauthorized use of suPAR Bio Intellectual Property constitutes a material breach of these Terms.

Data Use, Privacy, and HIPAA Status

Physician acknowledges that, in connection with facilitating laboratory test orders, coordinating specimen processing, and generating the official laboratory report and associated Result Report, suPAR Bio may receive or process certain patient information, including protected health information (“PHI”), on a minimum necessary basis.

suPAR Bio’s use of such information is limited to administrative functions related to order facilitation, laboratory coordination, report generation, quality review, regulatory compliance, and platform operation. suPAR Bio does not use PHI for independent clinical decision-making and does not establish a physician–patient relationship.

suPAR Bio may use de-identified and aggregated laboratory data for quality improvement, scientific validation, research, regulatory submissions, and publication purposes, provided no patient-identifiable information is disclosed.

Physician remains solely responsible for compliance with all applicable federal and state privacy laws, including the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), and for obtaining any required patient authorizations or consents related to testing and data transmission.

Nothing in these Terms creates or implies that suPAR Bio is acting as a “Business Associate” of Physician under HIPAA unless and until a separate Business Associate Agreement (“BAA”) is executed in writing by authorized representatives of both parties. In the absence of such separately executed BAA, suPAR Bio’s role is limited to the functions expressly described in these Terms.

Physician acknowledges that suPAR Bio does not control Physician’s internal data practices, workforce access controls, patient communications, or record retention policies.

Confidentiality of suPAR Bio Information

Physician acknowledges that certain information disclosed by suPAR Bio, including but not limited to pricing structures, partner portal access credentials, scientific data compilations, interpretive methodologies, training materials, operational procedures, marketing strategies, internal documents, and non-public business information (collectively, “Confidential Information”), is proprietary and confidential to suPAR Bio.

Physician agrees not to disclose, reproduce, distribute, or use any Confidential Information for any purpose other than purchasing and offering the suPAR Bio Test within Physician’s practice in accordance with these Terms.

Confidential Information does not include information that is publicly available through no fault of Physician or independently developed without use of suPAR Bio’s proprietary materials.

Unauthorized disclosure or misuse of Confidential Information shall constitute a material breach of these Terms and may result in immediate suspension or termination of Physician’s account.

Force Majeure; Shipping and Laboratory Delays

suPAR Bio shall not be liable for any delay, failure, or interruption in performance arising from causes beyond its reasonable control, including but not limited to acts of God; natural disasters; severe weather; public health emergencies; pandemics; governmental actions; regulatory restrictions; labor disputes; supply chain disruptions; reagent shortages; manufacturing delays; carrier delays; shipping interruptions; power outages; telecommunications failures; laboratory staffing shortages; laboratory capacity limitations; or other unforeseen operational events (each, a “Force Majeure Event”).

Without limitation, suPAR Bio shall not be liable for delays or disruptions affecting:
(i) outbound shipment of suPAR Bio Test kits;
(ii) overnight carrier delivery of specimens to the laboratory;
(iii) laboratory receipt timing;
(iv) laboratory processing timelines; or
(v) issuance of laboratory reports or Result Reports.

In the event of a Force Majeure Event, suPAR Bio’s obligations shall be suspended for the duration of the event and for a reasonable recovery period thereafter. Force Majeure Events shall not give rise to any claim for damages, penalties, refunds, lost profits, or other compensation.

suPAR Bio does not guarantee uninterrupted or continuous access to the suPAR Bio Partner Portal, reporting systems, or related digital infrastructure. suPAR Bio shall not be liable for temporary technical interruptions, scheduled maintenance, system updates, platform downtime, telecommunications failures, or other technology-related service disruptions.

Nothing in these Terms shall be construed as guaranteeing platform services, specific shipping timelines, specimen transit times, laboratory turnaround times, or reporting deadlines.

Term and Termination

These Terms become effective upon Physician’s acceptance of these Terms and creation of a suPAR Bio purchasing account and shall remain in effect indefinitely unless terminated as set forth herein.

suPAR Bio may suspend or terminate Physician’s account, authorization to purchase or resell the suPAR Bio Test, or access to related services at any time, with or without notice, in the event of: (i) any breach of these Terms; (ii) loss, suspension, restriction, or expiration of Physician’s medical license; (iii) exclusion, debarment, or ineligibility to participate in any federal or state healthcare program; (iv) failure to maintain required professional liability insurance; (v) regulatory risk or legal exposure arising from Physician’s conduct; or (vi) any activity that suPAR Bio determines, in its reasonable discretion, may harm patients, violate applicable law, or expose suPAR Bio to liability.

Physician may discontinue participation at any time by ceasing to purchase or resell the suPAR Bio Test; however, all obligations accrued prior to termination shall survive.

Upon termination or suspension, Physician shall immediately cease use of the suPAR Bio Test marketing materials, trademarks, and branded content, and shall not represent continued authorization to purchase or resell the suPAR Bio Test.

The provisions of these Terms relating to compliance with law, marketing restrictions, intellectual property, indemnification, limitation of liability, and any other provisions which by their nature should survive termination shall survive any expiration or termination of these Terms.

No Partnership, Agency, or Joint Venture

Nothing in these Terms shall be construed to create a partnership, joint venture, agency, employment, franchise, fiduciary, or other similar relationship between Physician and suPAR Bio. Physician is an independent healthcare provider acting solely on Physician’s own behalf and not as an agent, representative, or authorized spokesperson of suPAR Bio.

Physician shall not represent or imply that Physician has authority to bind suPAR Bio, enter into agreements on behalf of suPAR Bio, make commitments in suPAR Bio’s name, or act as a distributor or representative of suPAR Bio beyond the limited authorization expressly granted under these Terms.Each party is solely responsible for its own business operations, regulatory compliance, and liabilities.

Assignment

Physician may not assign, delegate, or transfer any rights or obligations under these Terms without the prior written consent of suPAR Bio. Any attempted assignment in violation of this Section shall be void.

suPAR Bio may assign or transfer these Terms without Physician’s consent in connection with a merger, acquisition, corporate restructuring, financing transaction, asset sale, or other corporate transaction, or to an affiliate. These Terms shall be binding upon and inure to the benefit of the parties and their permitted successors and assigns.

Amendments

suPAR Bio reserves the right to modify or update these Terms at any time in its sole discretion. Updated Terms shall become effective upon posting to the suPAR Bio Partner Portal or other official suPAR Bio communication channel.

suPAR Bio may, but is not obligated to, provide additional notice of material updates via email or portal notification.

Physician’s continued access to the suPAR Bio Partner Portal, purchase of the suPAR Bio Test, or use of any related services following the effective date of updated Terms constitutes Physician’s acceptance of such revised Terms.

If Physician does not agree to any modification, Physician must cease purchasing and utilizing the suPAR Bio Test.

Modifications shall apply prospectively and shall not retroactively alter obligations accrued prior to the effective date of such modification.

No Third-Party Beneficiaries

These Terms are for the sole benefit of Physician and suPAR Bio and do not create any rights in favor of any third party.

Governing Law

These Terms shall be governed by and construed in accordance with the laws of Puerto Rico, without regard to conflict-of-law principles. The parties agree that any dispute arising out of or relating to these Terms shall be brought exclusively in the state or federal courts located in San Juan, Puerto Rico, and each party hereby consents to the personal jurisdiction of such courts.

Arbitration and Dispute Resolution

Except as otherwise expressly provided below, any dispute, claim, or controversy arising out of or relating to these Terms, the suPAR Bio Test, the Result Report, the suPAR Bio Partner Portal, or the relationship between the parties (collectively, a “Dispute”) shall be resolved exclusively by final and binding arbitration administered by the American Arbitration Association (“AAA”) in accordance with its Commercial Arbitration Rules then in effect.

The arbitration shall be conducted by a single arbitrator experienced in commercial healthcare or life sciences matters. The seat and place of arbitration shall be San Juan, Puerto Rico. The arbitration proceedings and all related submissions shall be confidential to the fullest extent permitted by law.

The arbitrator shall have authority to award any relief available under applicable law, except that the arbitrator shall not award punitive or exemplary damages to the extent such damages are disclaimed elsewhere in these Terms. Judgment on the arbitration award may be entered in any court of competent jurisdiction.

Each party shall bear its own attorneys’ fees and costs unless otherwise awarded by the arbitrator in accordance with applicable law.

Injunctive Relief

Notwithstanding the foregoing, suPAR Bio may seek temporary, preliminary, or permanent injunctive or equitable relief in any court of competent jurisdiction to protect its intellectual property rights, confidential information, regulatory position, distribution controls, or to prevent unauthorized use or distribution of the suPAR Bio Test.

Waiver

No failure or delay by suPAR Bio in exercising any right, power, or remedy under these Terms shall operate as a waiver of such right, power, or remedy. Any waiver must be in writing and signed by an authorized representative of suPAR Bio.

Severability

If any provision of these Terms is held to be invalid, illegal, or unenforceable by a court or governmental authority of competent jurisdiction, such provision shall be modified to the minimum extent necessary to make it enforceable, and the remaining provisions shall remain in full force and effect.

Survival

The provisions of these Terms that by their nature should survive termination or expiration shall survive, including, without limitation, provisions relating to Indemnification, Limitation of Liability, Confidentiality, Intellectual Property, Payment Obligations, Regulatory Compliance Representations, Data and Privacy, and any other obligations that expressly or implicitly extend beyond termination.

Termination or suspension of Physician’s purchasing privileges shall not relieve Physician of any obligations accrued prior to termination.

Entire Agreement

These Terms constitute the entire agreement between Physician and suPAR Bio with respect to the subject matter herein and supersede all prior or contemporaneous understandings, representations, communications, or agreements, whether written or oral.

No amendment or modification of these Terms shall be binding unless made in writing by suPAR Bio or posted through the suPAR Bio Partner Portal in accordance with the Terms update provision. Physician acknowledges that no employee, agent, or representative of suPAR Bio is authorized to modify these Terms except through formal written amendment.

Electronic Acceptance

Physician acknowledges that acceptance of these Terms through electronic acknowledgment, account registration, or purchase through the suPAR Bio Partner Portal constitutes a legally binding agreement equivalent to a signed written contract.

Acknowledgment and Acceptance of Terms

By creating an account, accessing the suPAR Bio Partner Portal, purchasing the suPAR Bio Test, or otherwise offering or utilizing the suPAR Bio Test within Physician’s practice, Physician acknowledges that Physician has read, understood, and agrees to be legally bound by these Terms and Conditions.

Physician further represents and warrants that Physician has the authority to enter into this agreement on behalf of Physician’s medical practice and that such acceptance constitutes a binding and enforceable agreement under applicable law.

If Physician does not agree to these Terms, Physician must not access the suPAR Bio Partner Portal, purchase, resell, or utilize the suPAR Bio Test.

Continued access to or use of the suPAR Bio Test following any update to these Terms constitutes acceptance of the revised Terms.